Antifungal agents useful in therapy of systemic fungal infections.
about
Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycosesAntifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasisLimited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in ratsRoles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasisIn vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with IntralipidNew and emerging yeast pathogensParticulate contamination of lyophilized amphotericin B preparation during reconstitution process.Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profiles.Candida infections: an overview.Characterization of a labile naloxone binding site (lambda site) in rat brain.Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B.MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie.Chloride, not sodium, stimulates expression of the gamma subunit of Na/K-ATPase and activates JNK in response to hypertonicity in mouse IMCD3 cellsEnhanced action of amphotericin B on Leishmania mexicana resulting from heat transformationEffect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbitsInduction of amphotericin B-specific antibodies for use in immunoassays.Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cellsHydrophobic polyoxins are resistant to intracellular degradation in Candida albicans.Sensitivity of Candida albicans to amphotericin B administered as single or fractionated dosesInfluence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of miceDimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi.Interfaces of the yeast killer phenomenon.Liver injury associated with ketoconazole: review of the published evidence.New challenges to the therapy of systemic fungal infections.Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.Anti-Candida drugs--the biochemical basis for their activity.Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma.Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs.Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.Measurement of the concentration of amphotericin B in brain tissue of scrapie-infected hamsters with a simple and sensitive method.Effect of liposomal amphotericin B on murine macrophages and lymphocytes.Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
P2860
Q28318068-FF8BF298-4949-4FAE-88E7-638FAED59F38Q28325164-B85313CC-C0C3-4AE2-8D75-49C925E97886Q28333669-CFEF281C-C64B-4593-B42B-1E9BEDC52A5FQ28343835-143E27A3-A8B3-4EDC-85FB-1CBD9E8CACAEQ28369708-93B07CF2-B78D-43BD-9601-0FB9058732D6Q30452880-81178CC6-5C39-408E-AFF7-DCA7FD444B79Q30989176-E293431D-2284-4470-98AA-6236FB608626Q33742444-06198B04-880D-43A9-B425-591C904F0D46Q34174059-926B64E8-0A7B-4FCF-BFC5-5DAC26FF536DQ34564183-4FA6D803-7326-4438-9564-075EA5002F10Q34690274-4BDA0FC5-4A7F-4D40-9E68-3F62893759EAQ35113856-30989A1C-5945-4D30-99C9-F25BA373F8A9Q35121108-BBB281AB-257F-4150-9713-8910CC9591F0Q35143171-D866B6EC-D89A-4CE6-8891-041C91789FFFQ35269963-7997E8CD-B6C9-4A6B-9E78-DDBDFD91B7D3Q35537748-9DBC7529-E224-4B67-AD3E-53EE4C7F0D40Q35569453-1C4BB1BD-CEAC-4958-A131-50D6C44A5EE5Q35570273-264FF626-9169-4C6E-879E-9DADE394A126Q35571797-510A6686-CB69-4810-B4AE-52F173D48C5BQ35640961-B27BA3DD-4DDA-40CA-B773-F9DBA58448A7Q35641171-C3D37244-FC81-4A5C-870E-B2C664B73BA8Q35648297-0BB3C1D4-C3EC-4F55-969D-A581DDD16D17Q35649977-950034B4-8BAF-4374-BB8A-3132F3E0DD94Q35824054-A23AA1F6-F5F3-4EC4-B555-55CD9B3A2A04Q36980949-31799C45-2383-4285-BD75-6008ED4D1D84Q37012651-C2F8183F-2EFD-433D-ADA8-0165ED16D35CQ37055386-FEA1A422-526B-47AD-AAF2-BA05CA87C2C3Q37187943-A73A9E1D-F57E-432D-B661-4C08C4F14546Q38248677-79C46628-9FE6-4826-A5A1-7472B34D1531Q38298370-5AA2F1C4-D05D-408D-9D95-65DF82F17F8DQ39078243-2943626C-0C23-4A46-A992-FBFF048F807FQ39685115-99333358-33FE-4F7C-9611-1F69C29ECD31Q39782548-74F06CF1-B1AC-4CD2-A1A0-0F6D2A0365B4Q39784830-97C89A58-CC8D-47E6-86A9-5ACA0E906472Q39849411-B46F8A91-FFAC-447C-9420-E9F499F9A30AQ39851052-97979718-CC26-4782-B815-B76FFD728E85Q39867085-BD4C343D-4144-452C-9E20-EAB26FEF508FQ40086927-9A678291-5754-490E-8EFC-49E35885326EQ40176369-A8CB9E4F-4610-43F4-8DCB-D30F9C783871Q40310045-2B77DB38-875A-4039-9082-69FA0BF66FF6
P2860
Antifungal agents useful in therapy of systemic fungal infections.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Antifungal agents useful in therapy of systemic fungal infections.
@en
type
label
Antifungal agents useful in therapy of systemic fungal infections.
@en
prefLabel
Antifungal agents useful in therapy of systemic fungal infections.
@en
P2093
P1476
Antifungal agents useful in therapy of systemic fungal infections.
@en
P2093
Brajtburg J
Kobayashi GS
P304
P356
10.1146/ANNUREV.PA.23.040183.001511
P577
1983-01-01T00:00:00Z